SELLAS Life Sciences SLS
NASDAQ SLS
$12.14 +0.16 (+1.34%)
At close: Oct 21, 2026 · 4:00 PM EDT

SELLAS Life Sciences (SLS) Notes Payables (2011)

Updated

SELLAS Life Sciences (SLS) recorded Notes Payables of $500,000 in Q4 2011, unchanged from the prior quarter.

Analysis

SELLAS Life Sciences (SLS) Notes Payables (2011) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 SELLAS Life Sciences 2.30 Bn 1.94 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2011 500,000.00
Sep 30, 2011 500,000.00
API Access

SELLAS Life Sciences Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=SLS&period=max&api_key=YOUR_API_KEY